2nd Quarter - Report
BGR GOVERNMENT AFFAIRS for EIGER BIOPHARMACEUTICALS, INC.
Income
$60,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Provide strategic counsel and advocacy on issues impacting rare disease treatments and pharmaceutical industry generally, and Eiger Biopharmaceuticals, Inc. specifically.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT ALAN DEL MONTE | See prior filing |
| DANIEL FARMER | See prior filing |
| MATT HOFFMANN | See prior filing |
| REMY LEIGH BRIM MASON | See prior filing |
| JOHN STONE | See prior filing |
| ROBB WALTON | See prior filing |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.